Open1.450 | Close1.520 |
Vol / Avg.19.352K / 22.311K | Mkt Cap66.629M |
Day Range1.415 - 1.530 | 52 Wk Range0.900 - 2.100 |
Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Open1.450 | Close1.520 |
Vol / Avg.19.352K / 22.311K | Mkt Cap66.629M |
Day Range1.415 - 1.530 | 52 Wk Range0.900 - 2.100 |
H1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 17.296M |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.580 | -1.600 | -0.0200 | ||||
REV | 8.870M | 9.293M | 423.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-01 | HC Wainwright & Co. | Arthur He | Reiterates | BuyBuy | Maintains | - | 5.00 |
2023-04-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-29 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADAG | Adagene | 10.14% | 66.6M |
OTLK | Outlook Therapeutics | -1.32% | 56.5M |
INTS | Intensity Therapeutics | 1.04% | 53.4M |
TTOO | T2 Biosystems | -10.62% | 60.3M |
VTGN | Vistagen Therapeutics | -1.68% | 49.3M |
You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.
Other companies in Adagene’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO), Vistagen Therapeutics (NASDAQ:VTGN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Friday, September 1, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 228.95% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Adagene (NASDAQ: ADAG) is $1.52 last updated Today at September 27, 2023 at 7:59 PM UTC.
There is no dividend information for Adagene.
Adagene’s H1 earnings are confirmed for Thursday, August 31, 2023.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Open1.450 | Close1.520 |
Vol / Avg.19.352K / 22.311K | Mkt Cap66.629M |
Day Range1.415 - 1.530 | 52 Wk Range0.900 - 2.100 |
H1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 17.296M |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.580 | -1.600 | -0.0200 | ||||
REV | 8.870M | 9.293M | 423.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-01 | HC Wainwright & Co. | Arthur He | Reiterates | BuyBuy | Maintains | - | 5.00 |
2023-04-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-29 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADAG | Adagene | 10.14% | 66.6M |
OTLK | Outlook Therapeutics | -1.32% | 56.5M |
INTS | Intensity Therapeutics | 1.04% | 53.4M |
TTOO | T2 Biosystems | -10.62% | 60.3M |
VTGN | Vistagen Therapeutics | -1.68% | 49.3M |
You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.
Other companies in Adagene’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO), Vistagen Therapeutics (NASDAQ:VTGN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Friday, September 1, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 228.95% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Adagene (NASDAQ: ADAG) is $1.52 last updated Today at September 27, 2023 at 7:59 PM UTC.
There is no dividend information for Adagene.
Adagene’s H1 earnings are confirmed for Thursday, August 31, 2023.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Open1.450 | Close1.520 |
Vol / Avg.19.352K / 22.311K | Mkt Cap66.629M |
Day Range1.415 - 1.530 | 52 Wk Range0.900 - 2.100 |
H1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 17.296M |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.580 | -1.600 | -0.0200 | ||||
REV | 8.870M | 9.293M | 423.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-01 | HC Wainwright & Co. | Arthur He | Reiterates | BuyBuy | Maintains | - | 5.00 |
2023-04-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-29 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADAG | Adagene | 10.14% | 66.6M |
OTLK | Outlook Therapeutics | -1.32% | 56.5M |
INTS | Intensity Therapeutics | 1.04% | 53.4M |
TTOO | T2 Biosystems | -10.62% | 60.3M |
VTGN | Vistagen Therapeutics | -1.68% | 49.3M |
You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.
Other companies in Adagene’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO), Vistagen Therapeutics (NASDAQ:VTGN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Friday, September 1, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 228.95% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Adagene (NASDAQ: ADAG) is $1.52 last updated Today at September 27, 2023 at 7:59 PM UTC.
There is no dividend information for Adagene.
Adagene’s H1 earnings are confirmed for Thursday, August 31, 2023.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Open1.450 | Close1.520 |
Vol / Avg.19.352K / 22.311K | Mkt Cap66.629M |
Day Range1.415 - 1.530 | 52 Wk Range0.900 - 2.100 |
H1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 17.296M |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.580 | -1.600 | -0.0200 | ||||
REV | 8.870M | 9.293M | 423.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-01 | HC Wainwright & Co. | Arthur He | Reiterates | BuyBuy | Maintains | - | 5.00 |
2023-04-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-29 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADAG | Adagene | 10.14% | 66.6M |
OTLK | Outlook Therapeutics | -1.32% | 56.5M |
INTS | Intensity Therapeutics | 1.04% | 53.4M |
TTOO | T2 Biosystems | -10.62% | 60.3M |
VTGN | Vistagen Therapeutics | -1.68% | 49.3M |
You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.
Other companies in Adagene’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO), Vistagen Therapeutics (NASDAQ:VTGN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Friday, September 1, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 228.95% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Adagene (NASDAQ: ADAG) is $1.52 last updated Today at September 27, 2023 at 7:59 PM UTC.
There is no dividend information for Adagene.
Adagene’s H1 earnings are confirmed for Thursday, August 31, 2023.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Open1.450 | Close1.520 |
Vol / Avg.19.352K / 22.311K | Mkt Cap66.629M |
Day Range1.415 - 1.530 | 52 Wk Range0.900 - 2.100 |
H1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 17.296M |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.580 | -1.600 | -0.0200 | ||||
REV | 8.870M | 9.293M | 423.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-01 | HC Wainwright & Co. | Arthur He | Reiterates | BuyBuy | Maintains | - | 5.00 |
2023-04-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-29 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADAG | Adagene | 10.14% | 66.6M |
OTLK | Outlook Therapeutics | -1.32% | 56.5M |
INTS | Intensity Therapeutics | 1.04% | 53.4M |
TTOO | T2 Biosystems | -10.62% | 60.3M |
VTGN | Vistagen Therapeutics | -1.68% | 49.3M |
You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.
Other companies in Adagene’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO), Vistagen Therapeutics (NASDAQ:VTGN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Friday, September 1, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 228.95% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Adagene (NASDAQ: ADAG) is $1.52 last updated Today at September 27, 2023 at 7:59 PM UTC.
There is no dividend information for Adagene.
Adagene’s H1 earnings are confirmed for Thursday, August 31, 2023.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Open1.450 | Close1.520 |
Vol / Avg.19.352K / 22.311K | Mkt Cap66.629M |
Day Range1.415 - 1.530 | 52 Wk Range0.900 - 2.100 |
H1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 17.296M |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.580 | -1.600 | -0.0200 | ||||
REV | 8.870M | 9.293M | 423.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-01 | HC Wainwright & Co. | Arthur He | Reiterates | BuyBuy | Maintains | - | 5.00 |
2023-04-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-29 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADAG | Adagene | 10.14% | 66.6M |
OTLK | Outlook Therapeutics | -1.32% | 56.5M |
INTS | Intensity Therapeutics | 1.04% | 53.4M |
TTOO | T2 Biosystems | -10.62% | 60.3M |
VTGN | Vistagen Therapeutics | -1.68% | 49.3M |
You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.
Other companies in Adagene’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO), Vistagen Therapeutics (NASDAQ:VTGN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Friday, September 1, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 228.95% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Adagene (NASDAQ: ADAG) is $1.52 last updated Today at September 27, 2023 at 7:59 PM UTC.
There is no dividend information for Adagene.
Adagene’s H1 earnings are confirmed for Thursday, August 31, 2023.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Open1.450 | Close1.520 |
Vol / Avg.19.352K / 22.311K | Mkt Cap66.629M |
Day Range1.415 - 1.530 | 52 Wk Range0.900 - 2.100 |
H1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 17.296M |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.580 | -1.600 | -0.0200 | ||||
REV | 8.870M | 9.293M | 423.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-01 | HC Wainwright & Co. | Arthur He | Reiterates | BuyBuy | Maintains | - | 5.00 |
2023-04-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-29 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADAG | Adagene | 10.14% | 66.6M |
OTLK | Outlook Therapeutics | -1.32% | 56.5M |
INTS | Intensity Therapeutics | 1.04% | 53.4M |
TTOO | T2 Biosystems | -10.62% | 60.3M |
VTGN | Vistagen Therapeutics | -1.68% | 49.3M |
You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.
Other companies in Adagene’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO), Vistagen Therapeutics (NASDAQ:VTGN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Friday, September 1, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 228.95% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Adagene (NASDAQ: ADAG) is $1.52 last updated Today at September 27, 2023 at 7:59 PM UTC.
There is no dividend information for Adagene.
Adagene’s H1 earnings are confirmed for Thursday, August 31, 2023.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Open1.450 | Close1.520 |
Vol / Avg.19.352K / 22.311K | Mkt Cap66.629M |
Day Range1.415 - 1.530 | 52 Wk Range0.900 - 2.100 |
H1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 17.296M |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.580 | -1.600 | -0.0200 | ||||
REV | 8.870M | 9.293M | 423.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-01 | HC Wainwright & Co. | Arthur He | Reiterates | BuyBuy | Maintains | - | 5.00 |
2023-04-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-29 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADAG | Adagene | 10.14% | 66.6M |
OTLK | Outlook Therapeutics | -1.32% | 56.5M |
INTS | Intensity Therapeutics | 1.04% | 53.4M |
TTOO | T2 Biosystems | -10.62% | 60.3M |
VTGN | Vistagen Therapeutics | -1.68% | 49.3M |
You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.
Other companies in Adagene’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO), Vistagen Therapeutics (NASDAQ:VTGN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Friday, September 1, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 228.95% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Adagene (NASDAQ: ADAG) is $1.52 last updated Today at September 27, 2023 at 7:59 PM UTC.
There is no dividend information for Adagene.
Adagene’s H1 earnings are confirmed for Thursday, August 31, 2023.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Open1.450 | Close1.520 |
Vol / Avg.19.352K / 22.311K | Mkt Cap66.629M |
Day Range1.415 - 1.530 | 52 Wk Range0.900 - 2.100 |
H1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | ||||||
REV | 17.296M |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.580 | -1.600 | -0.0200 | ||||
REV | 8.870M | 9.293M | 423.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-01 | HC Wainwright & Co. | Arthur He | Reiterates | BuyBuy | Maintains | - | 5.00 |
2023-04-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-29 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
2023-03-21 | HC Wainwright & Co. | Arthur He | Reiterates | Buy | Maintains | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADAG | Adagene | 10.14% | 66.6M |
OTLK | Outlook Therapeutics | -1.32% | 56.5M |
INTS | Intensity Therapeutics | 1.04% | 53.4M |
TTOO | T2 Biosystems | -10.62% | 60.3M |
VTGN | Vistagen Therapeutics | -1.68% | 49.3M |
You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.
Other companies in Adagene’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO), Vistagen Therapeutics (NASDAQ:VTGN) and CollPlant Biotechnologies (NASDAQ:CLGN).
The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Friday, September 1, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 228.95% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Adagene (NASDAQ: ADAG) is $1.52 last updated Today at September 27, 2023 at 7:59 PM UTC.
There is no dividend information for Adagene.
Adagene’s H1 earnings are confirmed for Thursday, August 31, 2023.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.